Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study

• Shih-Yi Lin,

  Affiliations Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, Division of Nephrology and Kidney Institute, China Medical University Hospital, Taichung, Taiwan

  ⨯
• Cheng-Li Lin,

  Affiliations Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan, College of Medicine, China Medical University, Taichung, Taiwan

  ⨯
• Shu-Woei Ju,

  Affiliation Division of Nephrology and Kidney Institute, China Medical University Hospital, Taichung, Taiwan

  ⨯
• I-Kuan Wang,

  Affiliations Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, Division of Nephrology and Kidney Institute, China Medical University Hospital, Taichung, Taiwan

  ⨯
• Cheng-Chieh Lin,

  Affiliations Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan

  ⨯
• Chih-Hsueh Lin,

  Affiliations Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan

  ⨯
• Wu-Huei Hsu,

  Affiliations Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, Division of Pulmonary and Critical Care Medicine, China Medical University Hospital and China Medical University, Taichung, Taiwan

  ⨯
• Ji-An Liang

  * E-mail: d4615@mail.cmuh.org.tw

  Affiliations Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan

  http://orcid.org/0000-0002-4170-7155

  ⨯